| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,499 |
8,357 |
$423K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,918 |
2,576 |
$205K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,387 |
1,939 |
$177K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,265 |
1,976 |
$153K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,093 |
923 |
$77K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,406 |
1,245 |
$72K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,043 |
3,452 |
$65K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
781 |
647 |
$61K |
| 96127 |
|
3,722 |
3,179 |
$53K |
| 87428 |
|
617 |
588 |
$38K |
| 99460 |
|
732 |
678 |
$34K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
993 |
898 |
$29K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
762 |
694 |
$27K |
| D1206 |
Topical application of fluoride varnish |
732 |
592 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,089 |
1,016 |
$16K |
| 90670 |
|
1,780 |
1,447 |
$16K |
| 90686 |
|
1,520 |
1,271 |
$14K |
| 83655 |
|
856 |
704 |
$10K |
| 90648 |
|
1,404 |
1,184 |
$10K |
| 90680 |
|
1,068 |
871 |
$8K |
| 87807 |
|
783 |
709 |
$8K |
| 90723 |
|
1,033 |
880 |
$7K |
| 90633 |
|
690 |
525 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
233 |
223 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
448 |
408 |
$6K |
| 0071A |
|
130 |
98 |
$5K |
| 90710 |
|
459 |
335 |
$4K |
| 0072A |
|
84 |
74 |
$3K |
| 81002 |
|
1,376 |
1,174 |
$3K |
| 0002A |
|
73 |
65 |
$3K |
| 85018 |
|
1,254 |
1,041 |
$3K |
| 99000 |
|
121 |
100 |
$3K |
| 90651 |
|
187 |
137 |
$3K |
| 0001A |
|
61 |
60 |
$3K |
| 90697 |
|
162 |
121 |
$2K |
| 87400 |
|
146 |
120 |
$2K |
| 90734 |
|
153 |
111 |
$2K |
| 80061 |
Lipid panel |
280 |
141 |
$2K |
| 90696 |
|
84 |
56 |
$898.23 |
| 90619 |
|
57 |
44 |
$856.58 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
49 |
38 |
$697.45 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
52 |
42 |
$591.21 |
| 90671 |
|
29 |
25 |
$527.36 |
| 90656 |
|
27 |
27 |
$470.91 |
| 90700 |
|
54 |
42 |
$425.68 |
| 90715 |
|
62 |
38 |
$371.20 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13 |
13 |
$304.08 |
| 90685 |
|
13 |
13 |
$151.03 |
| 36416 |
|
12 |
12 |
$49.20 |
| 99177 |
|
126 |
108 |
$0.00 |
| 99072 |
|
38 |
36 |
$0.00 |
| 99051 |
|
56 |
52 |
$0.00 |